ENTITY

Capricor Therapeutics (CAPR US)

5
Analysis
Health CareUnited States
Capricor Therapeutics, Inc. operates as a clinical stage biotechnology company. The Company focuses on the development and commercialization of biological therapies for the treatment of duchenne muscular dystrophy (DMD) and other rare disorders. Capricor Therapeutics serves healthcare sector in the United States and Canada.
more
Company Event28 Feb 2026 05:00 • Upcoming
Add To Calendar
Company Event04 Dec 2025 00:30 • Latest
Company Event11 Nov 2025 05:30
Company Event25 Sep 2025 20:30
x